---
title: "Apellis Pharmaceuticals Officer Sells Shares to Cover Taxes"
date: "2025-02-13 03:00:09"
summary: "Reporter NameDelong Mark JeffreyRelationshipChief Business &amp; Strat OfficerTypeSellAmount$10,359SEC FilingForm 4Mark Jeffrey DeLong, Chief Business &amp; Strategic Officer at Apellis Pharmaceuticals, sold 363 shares of Common Stock on February 11, 2025, at a price of $28.5388 per share, totaling $10,359. This sale was conducted to cover tax withholding obligations related to..."
categories:
  - "TradingView"
lang:
  - "en"
translations:
  - "en"
tags:
  - "TradingView"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

| Reporter Name | Delong Mark Jeffrey |
| --- | --- |
| Relationship | Chief Business & Strat Officer |
| Type | Sell |
| Amount | $10,359 |
| SEC Filing | [Form 4](https://www.sec.gov/Archives/edgar/data/1856078/000112760225004328/xslF345X05/form4.xml) |

Mark Jeffrey DeLong, Chief Business & Strategic Officer at Apellis Pharmaceuticals, sold 363 shares of Common Stock on February 11, 2025, at a price of $28.5388 per share, totaling $10,359. This sale was conducted to cover tax withholding obligations related to the release of Restricted Stock Units on January 10, 2025. Following this transaction, DeLong directly owns 83,945 shares of Apellis Pharmaceuticals.

SEC Filing: [Apellis Pharmaceuticals, Inc. [ APLS ] - Form 4 - Feb. 12, 2025](https://www.sec.gov/Archives/edgar/data/1856078/000112760225004328/xslF345X05/form4.xml)

[TradingView](https://www.tradingview.com/news/tradingview:e2d19adf2e997:0-apellis-pharmaceuticals-officer-sells-shares-to-cover-taxes/)
